Increase/Decrease in Cash: The total change in cash for the company over the given period.
OnKure Therapeutics, Inc. (OKUR) had Increase/Decrease in Cash of $-51.71M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-13.50M |
|
-- |
|
-- |
|
$14.12M |
|
$-14.12M |
|
$0.62M |
|
$-13.50M |
|
$-13.50M |
|
$-13.50M |
|
$-13.50M |
|
$-13.50M |
|
$-13.50M |
|
$-14.12M |
|
$-13.92M |
|
13.52M |
|
13.52M |
|
$-0.98 |
|
$-0.98 |
|
| Balance Sheet Financials | |
$60.84M |
|
$0.62M |
|
$1.28M |
|
$62.12M |
|
$5.92M |
|
-- |
|
$0.01M |
|
$5.93M |
|
$56.18M |
|
$56.18M |
|
$56.18M |
|
13.67M |
|
| Cash Flow Statement Financials | |
$-51.83M |
|
$-0.05M |
|
$0.16M |
|
$110.76M |
|
$59.05M |
|
|
Increase/Decrease in Cash |
$-51.71M |
$11.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-51.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.03% |
|
-24.03% |
|
-21.74% |
|
-24.03% |
|
$4.11 |
|
$-3.84 |
|
$-3.83 |
|